secwatch.observer — SEC 8-K summary
======================================

Issuer:     SOLESENCE, INC. (SLSN)
CIK:        0000883107
Form:       8-K
Filed at:   2024-08-06T23:59:59+00:00
Accession:  0001171843-24-004480
Event type: earnings
Sentiment:  positive
Materiality: 0.65
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Nanophase reports record Q2 revenue $13M (+10% YoY) and net income $856K (+157%)
--------------------------------------------------------------------------------

- Q2 revenue $13M vs $11.9M in Q2 2023 (+10%); Solésence revenue $11.2M (+44% YoY).
- First half 2024 net income $1.7M vs loss $0.8M in H1 2023; gross profit $7.3M (+26%).
- Second half revenue expected to exceed first half by more than 20% per management.
- Won third consecutive Cosmopack North America Formulation Award for Lip Oil SPF 40+.
- Q2 net income $856K vs $333K in prior year period, a 157% increase.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/883107/000117184324004480/0001171843-24-004480-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/883107/000117184324004480/f8k_080624.htm
  HTML page:      https://secwatch.observer/filing/0001171843-24-004480

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer